PF-Atlas › Clinical Trials › NCT00359736

Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis

sildenafil · Phase 2

Registry ID
NCT00359736
Phase
Phase 2
Status
Completed
Drug / intervention
sildenafil
Sponsor
VA Office of Research and Development
Start
2006-07
Enrollment
29
Locations
1

About this trial

Medicines that decrease blood pressure in the lungs may help idiopathic pulmonary fibrosis (IPF) patients function better. This study will test whether sildenafil improves the ability to exercise in patients with pulmonary fibrosis of unknown cause.

View NCT00359736 on ClinicalTrials.gov →

Explore related

All sildenafil trialsAll IPF trials

Related trials

Sildenafil — NCT00352482sildenafil — NCT00659529Sildenafil — NCT01194232Sildenafil — NCT02057458Sildenafil — NCT00981747sildenafil — NCT02626182
Medical disclaimer. This page summarizes public trial data for NCT00359736 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.